COVID Test Shipments Top One Million Per Day
AdvaMed® announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association’s National Testing Registry.
Diagnostics
Learn more about our Diagnostics work.
AdvaMed® Unveils National Testing Registry to Aid in Fight Against COVID-19, Releases First Data Set
Whitaker Calls National Registry “Crucial Tool” for Federal, State Authorities; Announces More Than 65 Million Tests Shipped Nationwide Since Beginning of Pandemic WASHINGTON, D.C. – In its latest action to help ensure…
AdvaMedDx® Statement On Serology/Antibody Testing
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today released the following statement from Susan Van Meter, executive director of AdvaMedDx®, in response to comments on COVID-19 serology/antibody testing at today’s hearing…
AdvaMedDx® VALID Assessment Framework
AdvaMedDx® developed the VALID Assessment Framework as a tool to analyze the legislation.
Medtech Companies Are Manufacturing Critical COVID-19 Tests
Doctors, nurses and health care providers fighting on the front lines against the coronavirus are modern-day heroes. Every day they selflessly risk their own health to provide essential care to…
AdvaMedDx® COVID-19 Testing Infographic
This infographic depicts the process of COVID-19 diagnostic tests from patient sample to test results.
VALID Act 2020 Comprehensive Summary
The VALID Act seeks to modernize FDA oversight of in vitro diagnostics.
Diagnostics Manufacturers Ramping Up COVID-19 Tests to Combat Pandemic
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19). …
AdvaMedDx® VALID Act Webinar, March 20, 2020 – Presentation
On March 5, 2020, the VALID Act was introduced in the Senate and House.
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…